QIAGEN Reveals a Sensitive Side

Volume 16 | Issue 13 | 37 | Jun. 24, 2002 Previous | Next QIAGEN Reveals a Sensitive Side Highly sensitive microarrays provide a true expression profile | By Hillary E. Sussman Photo: Courtesy of Qiagen SensiChip DNA microarray bar Since their inception, DNA microarrays have been valuable in fields ranging from drug discovery to agricultural engineering. But the high-density chips suited

Written byHillary Sussman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Since their inception, DNA microarrays have been valuable in fields ranging from drug discovery to agricultural engineering. But the high-density chips suited for large-scale screening of differential gene expression patterns lack the sensitivity necessary for in-depth, secondary analysis of the resultant target genes. Netherlands-based QIAGEN saw this gap in the DNA microarray market and decided to close it with the SensiChip™ DNA Microarray System, an amplification-free technology that provides the true expression profile of a cell. The company recently unveiled SensiChip at Analytica 2002 in Munich, Germany. Developed in collaboration with Zeptosens, SensiChip is based on planar waveguide (PWG) technology that enables highly sensitive microarray analysis with as little as 1 µg total RNA.

SensiChip microarrays are coated with a thin film of tantalum pentoxide (Ta2O5), which has a higher refractive index than the glass slide. A laser beam, directed into the thin PWG layer by a coupling grating, propagates ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies